CytoReason

Welcome to In Vivo’s new AI-focused blog, BioBytes , providing news and insight on the growing role of artificial intelligence in biopharma. In Israel, four big pharma competitors have come togethe

The confluence of data science and molecular biology fuels expectations among biopharma industry leaders for another year of breakthrough innovation in human therapeutics. More than 70 executives and

Who: Pfizer Inc. and CytoReason What: The New York biopharma giant and the Israeli biotech have extended their three-year-old partnership focused on immune-mediated and immuno-oncology indicati

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Alliances With F-star And Xencor Featur